Current Treatment Landscape of Advanced Papillary Renal Cancer

被引：13
作者：
Shuch, Brian [1 ]
Hahn, Andrew W. [2 ]
Agarwal, Neeraj [2 ,3 ]
机构：
[1] Yale Sch Med, New Haven, CT 06510 USA
[2] Univ Utah, Sch Med, Salt Lake City, UT USA
[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 26期
关键词：
CELL CARCINOMA; PHASE-II; SUNITINIB;
D O I：
10.1200/JCO.2017.74.3328
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2981 / +
页数：4
相关论文
共 50 条
  • [21] Current State of Chemotherapy in Treatment of Advanced Penile Cancer
    Seitz, A. K.
    Protzel, C.
    Retz, M.
    AKTUELLE UROLOGIE, 2014, 45 (04) : 286 - 292
  • [22] Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective
    Lavacchi, Daniele
    Pellegrini, Elisa
    Palmieri, Valeria Emma
    Doni, Laura
    Mela, Marinella Micol
    Di Maida, Fabrizio
    Amedei, Amedeo
    Pillozzi, Serena
    Carini, Marco
    Antonuzzo, Lorenzo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (13) : 1 - 21
  • [23] How to Treat Renal Cell Carcinoma The Current Treatment Landscape and Cardiovascular Toxicities
    Castro, Daniela, V
    Malhotra, Jasnoor
    Meza, Luis
    Govindarajan, Ameish
    Philip, Errol J.
    Pal, Sumanta K.
    JACC: CARDIOONCOLOGY, 2022, 4 (02): : 271 - 275
  • [24] Treatment of locally advanced renal tumors
    Sanchez Zalabardo, D.
    Millan Serrano, J. A.
    De Pablo Cardenas, A.
    Cuesta Alcala, J. A.
    ACTAS UROLOGICAS ESPANOLAS, 2010, 34 (02): : 134 - 141
  • [25] Treatment of metastatic renal cancer: current validity of immunotherapy
    Llarena Ibarguren, Roberto
    ACTAS UROLOGICAS ESPANOLAS, 2009, 33 (05): : 584 - 592
  • [26] Current management of advanced melanoma: a transformed landscape
    Gyorki, David E.
    Spillane, John
    Speakman, David
    Shackleton, Mark
    Henderson, Michael A.
    ANZ JOURNAL OF SURGERY, 2014, 84 (09) : 612 - 617
  • [27] The current state of immune checkpoint inhibitors in the first-line treatment of renal cancer
    El Rassy, Elie
    Abboud, Rita Maria Khoury
    Ibrahim, Nathalie
    Assi, Tarek
    Aoun, Fouad
    Kaftan, Joseph
    IMMUNOTHERAPY, 2018, 10 (12) : 1047 - 1052
  • [28] Papillary renal cell carcinoma: current and controversial issues
    Angori, Silvia
    Lobo, Joao
    Moch, Holger
    CURRENT OPINION IN UROLOGY, 2022, 32 (04) : 344 - 351
  • [29] Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry
    Staehler, Michael
    Goebell, Peter J.
    Mueller, Lothar
    Emde, Till-Oliver
    Wetzel, Natalie
    Kruggel, Lisa
    Jaenicke, Martina
    Marschner, Norbert
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (05) : 1307 - 1315
  • [30] Spontaneous Regression of Metastatic Papillary Renal Cell Cancer After Cessation of Treatment With Sorafenib
    Grenader, Tal
    Rosenbaum, Eli
    Zilber, Sofia
    Bogot, Naama
    Shavit, Linda
    CLINICAL GENITOURINARY CANCER, 2013, 11 (02) : 201 - 203
12345